Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real‐Life Cohort Study-Reference-Cited by-同舟云学术

Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real‐Life Cohort Study

Published:2021-11-22 Issue: Volume: Page:
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol Commun

Author:

Valenti Luca¹²^ORCID,Pelusi Serena¹²,Aghemo Alessio³,Gritti Sara⁴,Pasulo Luisa⁵,Bianco Cristiana²^ORCID,Iegri Claudia⁵,Cologni Giuliana⁶,Degasperi Elisabetta⁷^ORCID,D’Ambrosio Roberta⁷,Poggio Paolo⁸,Soria Alessandro⁹,Puoti Massimo¹⁰,Carderi Isabella¹¹,Pigozzi Marie Graciella¹²,Carriero Canio¹³^ORCID,Spinetti Angiola¹³,Zuccaro Valentina¹⁴,Memoli Massimo¹⁵,Giorgini Alessia¹⁶,Viganò Mauro¹⁷,Rumi Maria Grazia¹⁷,Re Tiziana¹⁸,Spinelli Ombretta¹⁹,Colombo Maria Chiara¹⁹,Quirino Tiziana²⁰,Menzaghi Barbara²⁰,Lorini Gianpaolo²¹,Pan Angelo²²,D’Arminio Monforte Antonella²³,Buscarini Elisabetta²⁴,Autolitano Aldo²⁵,Bonfanti Paolo²⁶,Terreni Natalia²⁷,Aimo Gianpiero²⁸,Mendeni Monia²⁹,Prati Daniele²^ORCID,Lampertico Pietro¹⁷³⁰^ORCID,Colombo Massimo¹⁵,Fagiuoli Stefano⁵,

Affiliation:

1. Department of Pathophysiology and Transplantation Università degli Studi di Milano Milano Italy

2. Precision Medicine Lab Department of Transfusion Medicine and Hematology Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milano Milano Italy

3. Department of Internal Medicine and Hepatology Humanitas University and Research Hospital Rozzano Italy

4. Fondazione Ricerca Ospedale di BergamoPapa Giovanni Hospital Bergamo Italy

5. Department of Gastroenterology and Hepatology Papa Giovanni Hospital Bergamo Italy

6. Department of Internal Medicine Papa Giovanni Hospital Bergamo Italy

7. Division of Gastroenterology & Hepatology Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milano Milano Italy

8. Department of Gastroenterology and Hepatology Papa Giovanni Hospital Bergamo Zingonia Italy

9. Division of Infectious Diseases San Gerardo Hospital–ASST Monza Monza Italy

10. Department of Infectious Diseases Hepatitis Center ASST Grande Ospedale Metropolitano Niguarda Milano Italy

11. ASST Bergamo Est Bergamo HCV Network Bergamo Italy

12. Department of Gastroenterology Spedali Civili Hospital Brescia Italy

13. Department of Infectious Diseases Spedali Civili Hospital–ASST Brescia Brescia Italy

14. Department of Infectious Diseases Fondazione IRCCS Policlinico San Matteo di Pavia Pavia Italy

15. Liver Center San Raffaele Scientific Institute IRCCS Milano Italy

16. Department of Gastroenterology and Hepatology San Paolo HospitalASST Santi Paolo e Carlo Milan Italy

17. Department of Gastroenterology and Hepatology San Giuseppe Hospital Milan Italy

18. Department of Gastroenterology and Hepatology Legnano Hospital–ASST Milano Ovest Milan Italy

19. Department of Gastroenterology and Hepatology Lariana Como Hospital Milan Italy

20. Department of Gastroenterology and Hepatology Busto Arsizio Hospital ASST Valle Olona Milan Italy

21. Department of Gastroenterology and Hepatology ASST Franciacorta Milan Italy

22. Department of Internal Medicine Ospedale di Cremona Cremona Italy

23. Department of Infectious Diseases San Paolo HospitalASST Santi Paolo e Carlo Milan Italy

24. Department of Gastroenterology Ospedale Maggiore Crema Italy

25. ASST Pavia Mortara Mortara Italy

26. Division of Infectious Diseases ASST Lecco Lecco Italy

27. Ospedale Como ‐ Valduce Como Italy

28. ASST Garda Desenzano‐Manerbio Italy

29. ASST Valcamonica Esine Italy

30. CRC “AM. and A. Migliavacca” Center for Liver Disease Università degli Studi di Milano Milano Italy

Funder

Gilead Sciences

Ministero della Salute

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

European Commission

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1851

Reference36 articles.

1. EASL recommendations on treatment of hepatitis C 2018;European Association for the Study of the Liver;J Hepatol,2018

2. Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation;Goldberg D;Gastroenterology,2017

3. Effects of eradicating hepatitis C virus infection in patients with cirrhosis differ with stage of portal hypertension;Di Marco V;Gastroenterology,2016

4. Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C;Aghemo A;Hepatology,2012

5. A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis;D'Ambrosio R;Hepatology,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin and Hepatocellular Carcinoma Risk Reduction in Diabetic Patients with Chronic Hepatitis C: Fact or Fiction?;Viruses;2023-12-17

2. Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients;International Journal of Cancer;2023-07-13

3. The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?;Cancers;2023-06-13

4. Influence of diabetes mellitus and effectiveness of metformin on hepatocellular carcinoma;Hepatology Research;2023-05-30

5. Metabolic dysfunction outperforms ultrasonographic steatosis to stratify hepatocellular carcinoma risk in patients with advanced hepatitis C cured with direct‐acting antivirals;Liver International;2023-04-10